Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G/A for TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TVTX).
- Disclosed ownership: 4.8%.
- Date of event: 31 Dec 2025.
PERCEPTIVE ADVISORS LLC - 31 Dec 2025 SCHEDULE 13G/A Report for TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TVTX)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- TVTX
- Shares outstanding
- 89,128,750 shares
- Disclosed Ownership
- 4,278,180 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:00:02 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 4.8% ownership in TRAVERE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TVTX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Oct 2025.
- Current filing was accepted on 17 Feb 2026, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 4.8% | 4,278,180 | 0 | 4,278,180 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 4.8% | 4,278,180 | 0 | 4,278,180 | /s/ Joseph Edelman | Joseph Edelman | |
| Perceptive Life Sciences Master Fund, Ltd. | 4.8% | 4,278,180 | 0 | 4,278,180 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |